Antigen Test Performance Among Children and Adults at a SARS-CoV-2 Community Testing Site

Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society 2021..

BACKGROUND: Performance characteristics of SARS-CoV-2 antigen tests among children are limited despite the need for point-of-care testing in school and childcare settings. We describe children seeking SARS-CoV-2 testing at a community site and compare antigen test performance to real-time reverse transcription-polymerase chain reaction (RT-PCR) and viral culture.

METHODS: Two anterior nasal specimens were self-collected for BinaxNOW antigen and RT-PCR testing, along with demographics, symptoms, and exposure information from individuals ≥5 years at a community testing site. Viral culture was attempted on residual antigen or RT-PCR-positive specimens. Demographic and clinical characteristics, and the performance of SARS-CoV-2 antigen tests, were compared among children (<18 years) and adults.

RESULTS: About 1 in 10 included specimens were from children (225/2110); 16.4% (37/225) were RT-PCR-positive. Cycle threshold values were similar among RT-PCR-positive specimens from children and adults (22.5 vs 21.3, P = .46) and among specimens from symptomatic and asymptomatic children (22.5 vs 23.2, P = .39). Sensitivity of antigen test compared to RT-PCR was 73.0% (27/37) among specimens from children and 80.8% (240/297) among specimens from adults; among specimens from children, specificity was 100% (188/188), positive and negative predictive values were 100% (27/27) and 94.9% (188/198), respectively. Virus was isolated from 51.4% (19/37) of RT-PCR-positive pediatric specimens; all 19 had positive antigen test results.

CONCLUSIONS: With lower sensitivity relative to RT-PCR, antigen tests may not diagnose all positive COVID-19 cases; however, antigen testing identified children with live SARS-CoV-2 virus.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:10

Enthalten in:

Journal of the Pediatric Infectious Diseases Society - 10(2021), 12 vom: 31. Dez., Seite 1052-1061

Sprache:

Englisch

Beteiligte Personen:

Ford, Laura [VerfasserIn]
Whaley, Melissa J [VerfasserIn]
Shah, Melisa M [VerfasserIn]
Salvatore, Phillip P [VerfasserIn]
Segaloff, Hannah E [VerfasserIn]
Delaney, Augustina [VerfasserIn]
Currie, Dustin W [VerfasserIn]
Boyle-Estheimer, Lauren [VerfasserIn]
O'Hegarty, Michelle [VerfasserIn]
Morgan, Clint N [VerfasserIn]
Meece, Jennifer [VerfasserIn]
Ivacic, Lynn [VerfasserIn]
Thornburg, Natalie J [VerfasserIn]
Tamin, Azaibi [VerfasserIn]
Harcourt, Jennifer L [VerfasserIn]
Folster, Jennifer M [VerfasserIn]
Medrzycki, Magdalena [VerfasserIn]
Jain, Shilpi [VerfasserIn]
Wong, Phili [VerfasserIn]
Goffard, Kimberly [VerfasserIn]
Gieryn, Douglas [VerfasserIn]
Kahrs, Juliana [VerfasserIn]
Langolf, Kimberly [VerfasserIn]
Zochert, Tara [VerfasserIn]
Tate, Jacqueline E [VerfasserIn]
Hsu, Christopher H [VerfasserIn]
Kirking, Hannah L [VerfasserIn]

Links:

Volltext

Themen:

Antigens, Viral
COVID-19
Epidemiology
Infectious diseases
Journal Article
Pediatrics
Public health

Anmerkungen:

Date Completed 04.01.2022

Date Revised 01.01.2023

published: Print

Citation Status MEDLINE

doi:

10.1093/jpids/piab081

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM330112929